Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Goffin

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Journal of the American Academy of Dermatology|September 1, 1995
Surfactant-induced dermatitis: comparison of corneosurfametry with predictive testing on human and reconstructed skinG E Piérard, V Goffin, T Hermanns-Lê, et al.
Maturitas|May 8, 1998
Sensitive skin at menopause; dew point and electrometric properties of the stratum corneumF Paquet, C Piérard-Franchimont, I Fumal, et al.
Revue Medicale De Liege|May 10, 2000
[Tea time ... a privileged moment in preventing cancer?]G E Piérard, J F Hermanns, T Hermanns-Lê, et al.
Revue Medicale De Liege|May 25, 2005
[Laser and pulsed light treatments]P Paquet, C Piérard-Franchimont, F Henry, et al.
The Journal of Biological Chemistry|July 12, 1996
Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassayV Goffin, S Kinet, F Ferrag, et al.
Oncogene|October 14, 2000
Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferationM Llovera, C Pichard, S Bernichtein, et al.
Endocrinology|August 5, 1999
The human growth hormone antagonist B2036 does not interact with the prolactin receptorV Goffin, S Bernichtein, O Carrière, et al.
Revue Medicale De Liege|May 1, 1994
[Wrinkles and skin microrelief. Modifications by alpha hydroxy acid]C Piérard-Franchimont, F Deleixhe-Mauhin, A Dubois, et al.
Endocrinology|November 1, 1995
Biological activity and immunological reactivity of human prolactin mutantsH K Rhee, Z Sun, S S Kim, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 5, 2020
[TMPRSS2-Erg/AR-V7: Prognostic value of tests in urine and biopsy rince material in prostate cancer]G Plante, P-N Bories, L Denjean, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Journal of the American Academy of Dermatology|September 1, 1995
Surfactant-induced dermatitis: comparison of corneosurfametry with predictive testing on human and reconstructed skinG E Piérard, V Goffin, T Hermanns-Lê, et al.
Maturitas|May 8, 1998
Sensitive skin at menopause; dew point and electrometric properties of the stratum corneumF Paquet, C Piérard-Franchimont, I Fumal, et al.
Revue Medicale De Liege|May 10, 2000
[Tea time ... a privileged moment in preventing cancer?]G E Piérard, J F Hermanns, T Hermanns-Lê, et al.
Revue Medicale De Liege|May 25, 2005
[Laser and pulsed light treatments]P Paquet, C Piérard-Franchimont, F Henry, et al.
The Journal of Biological Chemistry|July 12, 1996
Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassayV Goffin, S Kinet, F Ferrag, et al.
Oncogene|October 14, 2000
Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferationM Llovera, C Pichard, S Bernichtein, et al.
Endocrinology|August 5, 1999
The human growth hormone antagonist B2036 does not interact with the prolactin receptorV Goffin, S Bernichtein, O Carrière, et al.
Revue Medicale De Liege|May 1, 1994
[Wrinkles and skin microrelief. Modifications by alpha hydroxy acid]C Piérard-Franchimont, F Deleixhe-Mauhin, A Dubois, et al.
Endocrinology|November 1, 1995
Biological activity and immunological reactivity of human prolactin mutantsH K Rhee, Z Sun, S S Kim, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 5, 2020
[TMPRSS2-Erg/AR-V7: Prognostic value of tests in urine and biopsy rince material in prostate cancer]G Plante, P-N Bories, L Denjean, et al.
Pageof 10